Rehan Verjee
Directeur/Bestuurslid bij TYRA BIOSCIENCES, INC.
Vermogen: - $ op 30-04-2024
Profiel
Rehan Verjee currently works at Precede Biosciences, Inc., as President, Chief Executive Officer & Director, Massachusetts Biotechnology Council, as Director, and Tyra Biosciences, Inc., as Independent Director from 2021.
Mr. Verjee also formerly worked at EMD Serono Canada, Inc., as Managing Director, Merck KGaA, as Global Head-Innovative Medicine Franchises, EMD Serono, Inc., as President from 2018 to 2021, and Merck KGaA, as Chief Marketing & Strategy Officer-Healthcare.
Mr. Verjee received his graduate degree from the University of Oxford.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
-.--% | 26-03-2024 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Rehan Verjee
| Bedrijven | Functie | Begin |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Directeur/Bestuurslid | 01-06-2021 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Directeur/Bestuurslid | - |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Algemeen Directeur | - |
Eerdere bekende functies van Rehan Verjee
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | 01-03-2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | President | 01-03-2021 |
| EMD Serono Canada, Inc. | Algemeen Directeur | - |
Opleiding van Rehan Verjee
| University of Oxford | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK KGAA | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
| EMD Serono Canada, Inc. | |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Commercial Services |